Autologous hematopoietic stem cell infusion
IIT2025001
Phase 2 mab active
Quick answer
Autologous hematopoietic stem cell infusion for Prolonged Cytopenia Following CAR-T Therapy is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Prolonged Cytopenia Following CAR-T Therapy
- Phase
- Phase 2
- Modality
- mab
- Status
- active